Healthcare provider profile · identity verified

Mamuna Faizi

Family Practice · NORTH LAUDERDALE, FL · NPI 1275020745

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	178
Amlodipine Besylate	Amlodipine Besylate	405	140
Losartan Potassium	Losartan Potassium	369	122
Gabapentin	Gabapentin	295	107
Rosuvastatin Calcium	Rosuvastatin Calcium	291	112
Metformin Hcl	Metformin Hcl	285	95
Albuterol Sulfate Hfa	Albuterol Sulfate	185	67
Levothyroxine Sodium	Levothyroxine Sodium	183	54
Lisinopril	Lisinopril	183	63
Fluticasone Propionate	Fluticasone Propionate	180	92
Pantoprazole Sodium	Pantoprazole Sodium	178	64
Metoprolol Tartrate	Metoprolol Tartrate	173	57
Hydrochlorothiazide	Hydrochlorothiazide	162	60
Carvedilol	Carvedilol	156	50
Tramadol Hcl	Tramadol Hcl	148	52
Omeprazole	Omeprazole	134	57
Furosemide	Furosemide	130	46
Metoprolol Succinate	Metoprolol Succinate	130	51
Glipizide	Glipizide	129	51
Tamsulosin Hcl	Tamsulosin Hcl	128	49
Azithromycin	Azithromycin	120	83
Hydralazine Hcl	Hydralazine Hcl	101	36
Warfarin Sodium	Warfarin Sodium	96	17
Alendronate Sodium	Alendronate Sodium	93	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	34
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	88	30
Alprazolam	Alprazolam	85	22
Prednisone	Prednisone	85	37
Famotidine	Famotidine	84	31
Eliquis	Apixaban	83	24
Nifedipine Er	Nifedipine	80	30
Ozempic	Semaglutide	79	18
Diclofenac Sodium	Diclofenac Sodium	78	50
Triamcinolone Acetonide	Triamcinolone Acetonide	77	49
Allopurinol	Allopurinol	75	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	19
Tizanidine Hcl	Tizanidine Hcl	75	31
Clopidogrel	Clopidogrel Bisulfate	72	24
Methylprednisolone	Methylprednisolone	72	38
Mirtazapine	Mirtazapine	68	26
Montelukast Sodium	Montelukast Sodium	66	21
Glipizide Er	Glipizide	65	24
Sertraline Hcl	Sertraline Hcl	60	19
Simvastatin	Simvastatin	60	21
Ibuprofen	Ibuprofen	58	28
Jardiance	Empagliflozin	58	17
Trazodone Hcl	Trazodone Hcl	56	25
Atenolol	Atenolol	55	18
Meloxicam	Meloxicam	55	29
Zolpidem Tartrate	Zolpidem Tartrate	54	15
Duloxetine Hcl	Duloxetine Hcl	46	18
Oxybutynin Chloride Er	Oxybutynin Chloride	46	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	20
Latanoprost	Latanoprost	43	11
Meclizine Hcl	Meclizine Hcl	43	24
Novolog Flexpen	Insulin Aspart	42	suppressed
Valsartan	Valsartan	42	16
Farxiga	Dapagliflozin Propanediol	41	11
Escitalopram Oxalate	Escitalopram Oxalate	40	15
Finasteride	Finasteride	39	17
Vitamin D2	Ergocalciferol (Vitamin D2)	39	15
Spiriva Handihaler	Tiotropium Bromide	37	11
Wixela Inhub	Fluticasone Propion/Salmeterol	37	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	11
Levetiracetam	Levetiracetam	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	13
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	11
Pregabalin	Pregabalin	27	suppressed
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Temazepam	Temazepam	27	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Tadalafil	Tadalafil	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Bumetanide	Bumetanide	25	14
Spironolactone	Spironolactone	25	suppressed
Timolol Maleate	Timolol Maleate	25	suppressed
Metformin Hcl Er	Metformin Hcl	24	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	22	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Baclofen	Baclofen	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	13
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	19
Doxycycline Monohydrate	Doxycycline Monohydrate	19	17
Glimepiride	Glimepiride	19	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Nitroglycerin	Nitroglycerin	19	18
Nystatin	Nystatin	19	12
Levofloxacin	Levofloxacin	18	17
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Fluconazole	Fluconazole	17	11
Folic Acid	Folic Acid	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Sucralfate	Sucralfate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Naproxen	Naproxen	14	12
Ammonium Lactate	Ammonium Lactate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error